Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4051
PUT
Ares Capital
ARCC
$13.9B
| $614K | ﹤0.01% |
32,900
+10,600
| +48% | +$197K |
|
|
AUD
4052
DELISTED
Audacy, Inc.
AUD
| $612K | ﹤0.01% |
131,941
-12,910
| -9% | -$53.9K |
|
|
TPIC
4053
DELISTED
TPI Composites
TPIC
| $610K | ﹤0.01% |
32,971
+9,645
| +41% | +$177K |
|
4054
PUT
Quest Diagnostics
DGX
$26B
| $609K | ﹤0.01% |
5,700
-25,500
| -82% | -$2.66M |
|
4055
Hyster-Yale Materials Handling
HY
$725M
| $608K | ﹤0.01% |
10,320
+4,042
| +64% | +$225K |
|
4056
First Financial Corp
THFF
$979M
| $607K | ﹤0.01% |
13,275
+6,699
| +102% | +$295K |
|
|
DERM
4057
PUT
DELISTED
Dermira, Inc.
DERM
| $607K | ﹤0.01% |
+40,000
| New | +$345K |
|
4058
PUT
Dentsply Sirona
XRAY
$2.76B
| $606K | ﹤0.01% |
10,700
| – | – |
|
|
LDL
4059
DELISTED
Lydall, Inc.
LDL
| $606K | ﹤0.01% |
29,534
+8,581
| +41% | +$178K |
|
4060
CALL
Herbalife
HLF
$1.31B
| $605K | ﹤0.01% |
12,700
-5,900
| -32% | -$256K |
|
4061
PUT
Winnebago Industries
WGO
$904M
| $604K | ﹤0.01% |
11,400
+1,300
| +13% | +$60.8K |
|
4062
Ryder
R
$10.2B
| $603K | ﹤0.01% |
11,111
-15,610
| -58% | -$812K |
|
|
BRY
4063
DELISTED
Berry Corp
BRY
| $602K | ﹤0.01% |
63,846
+2,658
| +4% | +$24.9K |
|
4064
CALL
NovaGold Resources
NG
$3.02B
| $602K | ﹤0.01% |
67,200
+22,800
| +51% | +$158K |
|
4065
CALL
Darling Ingredients
DAR
$9.19B
| $601K | ﹤0.01% |
21,400
-100
| -0.5% | -$2.23K |
|
4066
Insteel Industries
IIIN
$635M
| $600K | ﹤0.01% |
27,909
+8,799
| +46% | +$186K |
|
|
FBMS
4067
DELISTED
The First Bancshares, Inc.
FBMS
| $600K | ﹤0.01% |
16,897
+5,578
| +49% | +$185K |
|
4068
Telephone and Data Systems
TDS
$4.03B
| $599K | ﹤0.01% |
23,548
-12,917
| -35% | -$317K |
|
|
CORR
4069
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $599K | ﹤0.01% |
13,402
+6,251
| +87% | +$284K |
|
4070
Krystal Biotech
KRYS
$9.64B
| $598K | ﹤0.01% |
10,807
+329
| +3% | +$16.1K |
|
4071
CALL
Yeti Holdings
YETI
$3.98B
| $598K | ﹤0.01% |
17,200
-200
| -1% | -$6.3K |
|
4072
American Coastal Insurance
ACIC
$531M
| $596K | ﹤0.01% |
47,284
+19,351
| +69% | +$246K |
|
4073
Mercantile Bank Corp
MBWM
$1.07B
| $596K | ﹤0.01% |
16,347
+8,104
| +98% | +$285K |
|
4074
York Water
YORW
$500M
| $596K | ﹤0.01% |
12,928
+6,536
| +102% | +$287K |
|
|
S
4075
PUT
DELISTED
Sprint Corporation
S
| $596K | ﹤0.01% |
114,300
-469,900
| -80% | -$2.75M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.